Possibilities for a role of L-glutamine and L-asparagine antagonists in the treatment of gastrointestinal cancer.
D000818:Animals; D001216:Asparagine / Q000037:antagonists & inhibitors*; D001391:Azo Compounds / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D005973:Glutamine / Q000037:antagonists & inhibitors*; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D014364:Tryptophan / Q000378:metabolism
D001391:Azo Compounds; D005973:Glutamine; D001216:Asparagine; D014364:Tryptophan; D005472:Fluorouracil